Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

Blood
C KearonJ A Julian

Abstract

It is uncertain whether antiphospholipid antibodies (APAs) increase the risk of recurrence after a first unprovoked venous thromboembolism (VTE). We tested for anticardiolipin antibodies, anti-β2 glycoprotein 1 antibodies, and lupus anticoagulant on 2 occasions ∼6 months apart in 307 patients with a first unprovoked VTE who were part of a prospective cohort study. We then determined if APAs were associated with recurrent thrombosis in the 290 patients who stopped anticoagulant therapy in response to negative D-dimer results. Compared with those without an APA, the hazard ratios for recurrent VTE were 1.8 (95% confidence interval [CI], 0.9-3.7; P = .09) in the 25.9% of patients with an APA on ≥1 occasions, 2.7 (95% CI, 1.1-.7; P = .03) in the 9.0% of patients with the same APA on 2 occasions, and 4.5 (95% CI, 1.5-13.0; P = .006) in the 3.8% of patients with 2 or 3 different APA types on either the same or different occasions. There was no association between having an APA and D-dimer levels. We conclude that having the same type of APA on 2 occasions or having >1 type of APA on the same or different occasions is associated with recurrent thrombosis in patients with a first unprovoked VTE who stop anticoagulant therapy in respons...Continue Reading

References

Jan 1, 1988·Annual Review of Medicine·E N HarrisG R Hughes
Oct 31, 2009·Journal of Thrombosis and Haemostasis : JTH·V PengoS Iliceto
May 18, 2010·BMJ : British Medical Journal·Danielle CohenIngeborg M Bajema
Sep 9, 2010·Lancet·Guillermo Ruiz-IrastorzaMunther A Khamashta
Jun 29, 2012·BMJ : British Medical Journal·Lee-Yee ChongUNKNOWN Guideline Development Group
Feb 20, 2013·Annals of Internal Medicine·Jill A HaydenClaire Bombardier
Mar 15, 2013·The New England Journal of Medicine·Bill Giannakopoulos, Steven A Krilis
Jan 7, 2015·Annals of Internal Medicine·Clive KearonUNKNOWN D-dimer Optimal Duration Study Investigators
Jul 20, 2016·Journal of Thrombosis and Haemostasis : JTH·C KearonUNKNOWN Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease

❮ Previous
Next ❯

Citations

May 29, 2018·International Journal of Laboratory Hematology·L ZhangZ Zhang
Sep 9, 2018·International Journal of Laboratory Hematology·Cyril JacquotScott C Kogan
May 12, 2018·Blood·Denis Wahl
Nov 15, 2018·Blood Advances·Marc Alan Rodger, Gregoire Le Gal
Oct 5, 2018·Annals of the Rheumatic Diseases·Imad UthmanMunther Khamashta
Dec 25, 2019·Journal of Thrombosis and Haemostasis : JTH·Sebastien MirandaAurélien Delluc
Jan 10, 2020·Blood·Clive Kearon, Susan R Kahn
Feb 7, 2020·Current Sports Medicine Reports·Zachary Devilbiss, Francis O'Connor
Sep 14, 2019·Journal of Thrombosis and Haemostasis : JTH·Walid ChayouaKatrien M J Devreese
Jan 29, 2019·Journal of Thrombosis and Haemostasis : JTH·Maha A T ElsebaieManila Gaddh
Nov 4, 2020·JAMA : the Journal of the American Medical Association·Romain ChopardGregory Piazza
Sep 9, 2020·Blood·Hannah Cohen, David A Isenberg
Jan 24, 2021·Thrombosis Research·Zara SayarHannah Cohen
Dec 17, 2020·Journal of Thrombosis and Haemostasis : JTH·Hannah CohenKatrien M J Devreese
May 2, 2021·Current Rheumatology Reports·Doruk ErkanUNKNOWN APS ACTION Executive Committee
May 11, 2021·Seminars in Thrombosis and Hemostasis·Jesus Aibar, Sam Schulman
May 14, 2021·Lancet·Faizan KhanMarc A Rodger
Jan 6, 2022·Current Rheumatology Reports·Jesse Y DabitAlí Duarte-García
Jan 6, 2022·Current Rheumatology Reports·Eleni Xourgia, Maria G Tektonidou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.